The pharmacologic inhibition of GSK3β with 9-ING-41(Elraglusib) can disrupt gemcitabine-induced DNA repair processes, leading to stimulated apoptosis in chemoresistant PC cells, which was reported in vitro and in vivo studies [160]. This evidence concerns the gene GSK3B and pachyonychia congenita.